[1]
“Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC”, Radiol Oncol, vol. 59, no. 4, pp. 617–623, Dec. 2025, Accessed: Sep. 21, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4451